<DOC>
	<DOCNO>NCT01382654</DOCNO>
	<brief_summary>The objective study : - Examine tolerability two formulation two dose concentration epinastine . - Select formulation ( ) epinastine future study evaluate individual sensory attribute score Nasal Spray Evaluation Questionnaire ( NSEQ ) collect study drug administration subject preference ranking assess completion study . - Compare preference two formulation two dose concentration epinastine compare azelastine follow single dose randomize , double-blind , two-cohort , three-period crossover design .</brief_summary>
	<brief_title>Two Formulations Concentrations Epinastine Nasal Spray Versus Azelastine Nasal Solution Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Epinastine</mesh_term>
	<mesh_term>Azelastine</mesh_term>
	<criteria>age 1870 history SAR PAR 1 year mild symptom asthma RAD respiratory tract infection within 14 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>